{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:55:39Z","timestamp":1780401339374,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer New York","isbn-type":[{"value":"9781493932917","type":"print"},{"value":"9781493932924","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3292-4_15","type":"book-chapter","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T17:43:37Z","timestamp":1458323017000},"page":"279-297","source":"Crossref","is-referenced-by-count":13,"title":["Methods for the Quality Control of Inactivated Poliovirus Vaccines"],"prefix":"10.1007","author":[{"given":"Thomas","family":"Wilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2822","key":"15_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.109.2822.85","volume":"109","author":"JF Enders","year":"1949","unstructured":"Enders JF, Weller TH, Robbins FC (1949) Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109(2822):85\u201387","journal-title":"Science"},{"issue":"5","key":"15_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2105\/AJPH.44.5.563","volume":"44","author":"JE Salk","year":"1954","unstructured":"Salk JE, Krech U, Youngner JS, Bennett BL, Lewis LJ, Bazeley PL (1954) Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines. Am J Public Health Nations Health 44(5):563\u2013570","journal-title":"Am J Public Health Nations Health"},{"issue":"3","key":"15_CR3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/infdis\/151.3.420","volume":"151","author":"AB Sabin","year":"1985","unstructured":"Sabin AB (1985) Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J Infect Dis 151(3):420\u2013436","journal-title":"J Infect Dis"},{"issue":"2","key":"15_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.biologicals.2006.02.008","volume":"34","author":"J Furesz","year":"2006","unstructured":"Furesz J (2006) Developments in the production and quality control of poliovirus vaccines\u2014historical perspectives. Biologicals 34(2):87\u201390","journal-title":"Biologicals"},{"key":"15_CR4","first-page":"17","volume-title":"Vaccines","author":"FC Robbins","year":"2004","unstructured":"Robbins FC (2004) The history of polio vaccine development. In: Plotkin SA, Orenstein WA (eds) Vaccines. Saunders, Philadelphia, pp 17\u201330"},{"key":"15_CR6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/B978-1-4160-3611-1.50029-5","volume-title":"Vaccine","author":"SA Plotkin","year":"2008","unstructured":"Plotkin SA, Vidor E (2008) Poliovirus vaccine\u2014inactivated. In: Plotkin SA, Orenstein WA, Offit PA (eds) Vaccine. Saunders Elsevier, Philadelphia, pp 605\u2013629"},{"issue":"5110","key":"15_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/216064a0","volume":"216","author":"AL van Wezel","year":"1967","unstructured":"van Wezel AL (1967) Growth of cell-strains and primary cells on micro-carriers in homogeneous culture. Nature 216(5110):64\u201365","journal-title":"Nature"},{"issue":"Pt 4","key":"15_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1099\/0022-1317-74-4-685","volume":"74","author":"M Ferguson","year":"1993","unstructured":"Ferguson M, Wood DJ, Minor PD (1993) Antigenic structure of poliovirus in inactivated vaccines. J Gen Virol 74(Pt 4):685\u2013690","journal-title":"J Gen Virol"},{"key":"15_CR9","doi-asserted-by":"crossref","first-page":"29.6","DOI":"10.1093\/oxfordjournals.aje.a120329","volume":"78","author":"N Nathanson","year":"1963","unstructured":"Nathanson N, Langmuir AD (1963) The Cutter incident: poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine. Am J Epidemiol 78:29.6\u201360.6","journal-title":"Am J Epidemiol"},{"key":"15_CR10","unstructured":"European Pharmacopoeia, 2.7.20 (2011) In vivo assay of poliomyelitis vaccine (inactivated). In: European Pharmacopoeia 7.0. pp 226\u2013227"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1017\/S002217240003936X","volume":"60","author":"AJ Beale","year":"1962","unstructured":"Beale AJ, Mason PJ (1962) The measurement of the D-antigen in poliovirus preparations. J Hyg (Lond) 60:113\u2013121","journal-title":"J Hyg (Lond)"},{"key":"15_CR12","first-page":"197","volume":"46","author":"M Souvras","year":"1980","unstructured":"Souvras M, Montagnon BJ, Fanget B, Van Wezel AL, Hazendonk AG (1980) Direct enzyme-linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen. Dev Biol Stand 46:197\u2013202","journal-title":"Dev Biol Stand"},{"key":"15_CR13","unstructured":"United States Department of Health Education and Welfare (1968) Biological Products Public Health Service, in 42, Public Health Service (ed). Division of Biological Standards National Institutes of Health, Maryland. pp 32\u201344"},{"issue":"5","key":"15_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF01245926","volume":"6","author":"S Gard","year":"1956","unstructured":"Gard S, Wesslen T, Fagraeus A, Svedmyr A, Olin G (1956) The use of guinea pigs in tests for immunogenic capacity of poliomyelitis virus preparations. Arch Gesamte Virusforsch 6(5):401\u2013411","journal-title":"Arch Gesamte Virusforsch"},{"issue":"5","key":"15_CR15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4049\/jimmunol.80.5.407","volume":"80","author":"EA Timm","year":"1958","unstructured":"Timm EA, Rope EZ, Mc LI Jr (1958) Chick potency tests of poliomyelitis vaccine: basic studies on response. J Immunol 80(5):407\u2013414","journal-title":"J Immunol"},{"key":"15_CR16","first-page":"119","volume":"47","author":"G van Steenis","year":"1981","unstructured":"van Steenis G, van Wezel AL, Sekhuis VM (1981) Potency testing of killed polio vaccine in rats. Dev Biol Stand 47:119\u2013128","journal-title":"Dev Biol Stand"},{"issue":"4","key":"15_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1006\/biol.1995.0049","volume":"23","author":"DJ Wood","year":"1995","unstructured":"Wood DJ, Heath AB (1995) A WHO collaborative study of immunogenicity assays of inactivated poliovirus vaccines. Biologicals 23(4):301\u2013311","journal-title":"Biologicals"},{"key":"15_CR18","unstructured":"European Pharmacopoeia (2014) In vivo assay of poliomyelitis vaccine (inactivated): test in rats. In: European Pharmacopoeia 8.0. Strasbourg, France"},{"issue":"Pt 7","key":"15_CR19","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1099\/vir.0.19088-0","volume":"84","author":"J Martin","year":"2003","unstructured":"Martin J, Crossland G, Wood DJ, Minor PD (2003) Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains. J Gen Virol 84(Pt 7):1781\u20131788","journal-title":"J Gen Virol"},{"issue":"2","key":"15_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/infdis\/175.2.441","volume":"175","author":"RE Taffs","year":"1997","unstructured":"Taffs RE, Chernokhvostova YV, Dragunsky EM, Nomura T, Hioki K, Beuvery EC, Fitzgerald EA, Levenbook IS, Asher DM (1997) Inactivated poliovirus vaccine protects transgenic poliovirus receptor mice against type 3 poliovirus challenge. J Infect Dis 175(2):441\u2013444","journal-title":"J Infect Dis"},{"key":"15_CR21","doi-asserted-by":"crossref","unstructured":"Jason-Moller L, Murphy M, Bruno J (2006) Overview of Biacore systems and their applications. Curr Protoc Protein Sci. Chapter 19:Unit 19 13","DOI":"10.1002\/0471140864.ps1913s45"},{"issue":"2","key":"15_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1385\/ABAB:126:2:079","volume":"126","author":"P Pattnaik","year":"2005","unstructured":"Pattnaik P (2005) Surface plasmon resonance: applications in understanding receptor-ligand interaction. Appl Biochem Biotechnol 126(2):79\u201392","journal-title":"Appl Biochem Biotechnol"},{"issue":"18","key":"15_CR23","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1016\/j.vaccine.2011.02.085","volume":"29","author":"J Westdijk","year":"2011","unstructured":"Westdijk J, Brugmans D, Martin J, Van\u2019t Oever A, Bakker WA, Levels L, Kersten G (2011) Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines. Vaccine 29(18):3390\u20133397","journal-title":"Vaccine"},{"issue":"15\u201316","key":"15_CR24","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0264-410X(98)00409-5","volume":"17","author":"G Kersten","year":"1999","unstructured":"Kersten G, Hazendonk T, Beuvery C (1999) Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains. Vaccine 17(15\u201316):2059\u20132066","journal-title":"Vaccine"}],"container-title":["Methods in Molecular Biology","Poliovirus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3292-4_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T23:14:20Z","timestamp":1676675660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-3292-4_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493932917","9781493932924"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3292-4_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}